Human germline gene editing results in a live birth before 2030.

Question

Six frontier AI models put this at 18% by 27 Oct 2031. Full reasoning from every model.

WillHappen.ai · Accepted Answer

18% — the median of 6 frontier models, resolving by 2031-10-27.

Answer

Gemini (Google): 34% — Strict global regulatory bans make approved clinical trials impossible by 2030, leaving rogue clinics as the primary pathway. Major regulatory bodies like the US FDA and UK HFEA require multi-year safety data on off-target effects before clearing trials. The 2018 He Jiankui births established precedent, but severe criminal backlash has chilled open rogue attempts in China and Russia. A permissive jurisdiction or underground fertility clinic attempting illicit implantation remains the only plausible route by 2030.

Answer

Claude (Anthropic): 6% — Turns on whether any rogue or state-tolerant actor repeats/extends He Jiankui-style editing before 2030. He Jiankui's 2018 CRISPR babies remain the only known case; global backlash produced near-universal bans and moratoria since. No country has legalized clinical germline editing; China, US, UK and most nations explicitly criminalize or heavily restrict it post-2018. Only a rogue lab evading oversight (as before) could produce another birth, which is possible but rare and hard to verify by 2031.

Answer

GPT (OpenAI): 18% — A birth requires a regulator to permit embryo editing despite a near-global clinical moratorium and major safety barriers. China's 2018 He Jiankui case produced births, but it triggered prosecutions, tighter rules, and WHO's 2021 governance framework. Before implantation, teams must show reliable on-target repair, minimal mosaicism and no harmful off-target effects in multigenerational-risk settings. A permissive clandestine program or a formal Chinese regulatory reversal by 2030 would raise the odds sharply.

Answer

Grok (xAI): 18% — A rogue implant of an edited human embryo must occur by early 2029 in a weakly regulated jurisdiction. He Jiankui’s 2018 twins remain the sole confirmed live births; China, the US, EU and WHO imposed clinical bans afterward. Rebrikov-style proposals never received ethics clearance, and mosaicism/off-target risks still deter even clandestine work. A 2027–28 pregnancy announcement from Russia, UAE or a private clinic would be the main upward surprise.

Answer

DeepSeek (DeepSeek): 12% — Whether a rogue clinic or permissive state implants edited embryos and carries a pregnancy to term within four years. He Jiankui's 2018 CRISPR twins show the technical path already exists, but he was jailed and no jurisdiction has since legalized implanting edited embryos. The WHO, ISSCR, and national regulators all call heritable editing unethical; Russia's 2021 'CRISPR baby' claim by Denis Rebrikov never produced a documented birth. Any credible attempt needs an IVF clinic, an ethics body, and a willing jurisdiction — none are publicly lined up, so the base rate of zero documented births in 8 years…

Answer

Qwen (Alibaba): 99% — He Jiankui's CCR5-edited twins were born in November 2018, making this statement already literally true. Lulu and Nana were born in 2018 after CRISPR-Cas9 editing of their embryos, satisfying the literal condition of the statement. No credible authority has retracted or disputed that these births occurred; the scientific record treats them as confirmed. The only way this resolves 'no' is if the resolution criteria exclude He Jiankui's case, which would require a non-literal reading.

Human germline gene editing results in a live birth before 2030.

A clinical trial begins testing a vascularized, 3D-bioprinted human organ in patients before 2032.

A fully lab-grown solid human organ is successfully transplanted into a patient before 2035.

Standard clinical turnaround for an ex vivo autologous gene editing therapy falls below 14 days before 2030.

An in vivo CRISPR gene editing therapy receives standard FDA approval before 2028.